Surgical management of amiodarone-associated thyrotoxicosis: Mayo clinic experience

World Journal of Surgery

Volumn 28, Issue 11, 2004, Pages 1083-1087

  Houghton, Scott G ^a   Farley, David R ^a   Brennan, Michael D ^a   Van Heerden, Jon A ^a   Thompson, Geoffrey B ^a   Grant, Clive S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FATIGUE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; HYPOTENSION; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; PNEUMONIA; POSTOPERATIVE COMPLICATION; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; REVIEW; SEPSIS; STROKE; SYMPTOM; THYROID SURGERY; THYROIDECTOMY; THYROTOXICOSIS; TREATMENT INDICATION; TREATMENT OUTCOME; TREMOR; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THYROIDECTOMY; THYROTOXICOSIS;

EID: 12144261848     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7599-6     Document Type: Review

References (23)

1. Brennan MD, van Heerden JA, Carney JA. Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management. Surgery 1987;102:1062-1067
2. Zipes DP, Prystowsky EN, Heger JS. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J. Am. Coll. Cardiol. 1984;3:1059-1071
3. Rao RH, McCready R, Spathis GS. Iodine kinetic studies during amiodarone treatment. J. Clin. Endocrinol. Metab. 1986;63:563-568
4. Daniels GH. Amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab. 2001;86:3-8
5. Brennan MD, Erickson DZ, Carney JA, et al. Nongoitrous (type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo. Thyroid 1995;5:177-183
6. Chopra IJ, Baber K. Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. J. Clin. Endocrinol. Metab. 2001;86:4707-4710
7. Claxton S, Sinha SN, Donovan S, et al. Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy. Aust. N. Z. J. Surg. 2000;70:174-178
8. Farwell AP, Abend SL, Huang SKS, et al. Thyroidectomy for amiodarone-induced thyrotoxicosis. J.A.M.A. 1990;11:1526-1528
9. Hamoir E, Meurisse M, Defechereux T, et al. Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective? World J. Surg. 1998;22:537-543
10. Mulligan DC, McHenry CR, Kinney W, et al. Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy. Surgery 1993;114:1114-1119
11. Nademanee K, Piwonka RW, Singh BN, et al. Amiodarone and thyroid function. Prog. Cardiovasc. Dis. 1989;31:427-437
12. Lombardi A, Martino E, Braverman LE. Amiodarone and the thyroid. Thyroid Today 1990;13:1-7
13. Martino E, Aghini-Lombardi F, Mariotti S, et al. Amiodarone iodine-induced hypothyroidism: risk factors and followup in 28 cases. Clin. Endocrinol. (Oxf.) 1987;26:227-237
14. Martino E, Bartalena L, Bogazzi F, et al. The effects of amiodarone on the thyroid. Endocr. Rev. 2001;22:240-254
15. Newman CM, Price A, Davies DW, et al. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998;79:121-127
16. Bartalena L, Brogioni S, Grasso L, et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J. Clin. Endocrinol. Metab. 1996;81:2930-2933
17. Eaton SE, Euinton HA, Newman CM, et al. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow doppler sonography. Clin. Endocrinol. (Oxf.) 2002;56:33-38
18. Osman F, Franklyn JA, Sheppard MC, et al. Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 2002;105:1275-1277
19. Martino E, Aghini-Lombardi F, Mariotti S, et al. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J. Endocrinol. Invest. 1986;9: 201-207
20. Reichert LJ, de Rooy HA. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. B.M.J. 1989;298:1547-1548
21. Bogazzi F, Miccoli P, Berti P, et al. Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 2002;132:1114-1118
22. Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch. Otolaryngol. Head Neck Surg. 2002;128:389-392
23. Bellantone R, Lombardi CP, Bossola M, et al. Total thyroidectomy for management of benign thyroid disease: review of 526 cases. World J. Surg. 2002;26:1468-1471